First Application of Mass Measurements with the Rare-RI Ring Reveals the Solar r-Process Abundance Trend at A=122 and A=123

The Rare-RI Ring (R3) is a recently commissioned cyclotronlike storage ring mass spectrometer dedicated to mass measurements of exotic nuclei far from stability at Radioactive Isotope Beam Factory (RIBF) in RIKEN. The first application of mass measurement using the R3 mass spectrometer at RIBF is reported. Rare isotopes produced at RIBF-^{127}Sn, ^{126}In, ^{125}Cd, ^{124}Ag, ^{123}Pd-were injected in R3. Masses of ^{126}In, ^{125}Cd, and ^{123}Pd were measured whereby the mass uncertainty of ^{123}Pd was improved. This is the first reported measurement with a new storage ring mass spectrometry technique realized at a heavy-ion cyclotron and employing individual injection of the preidentified rare nuclei. The latter is essential for the future mass measurements of the rarest isotopes produced at RIBF. The impact of the new ^{123}Pd result on the solar r-process abundances in a neutron star merger event is investigated by performing reaction network calculations of 20 trajectories with varying electron fraction Y_{e}. It is found that the neutron capture cross section on ^{123}Pd increases by a factor of 2.2 and β-delayed neutron emission probability, P_{1  n}, of ^{123}Rh increases by 14%. The neutron capture cross section on ^{122}Pd decreases by a factor of 2.6 leading to pileup of material at A=122, thus reproducing the trend of the solar r-process abundances. The trend of the two-neutron separation energies (S_{2n}) was investigated for the Pd isotopic chain. The new mass measurement with improved uncertainty excludes large changes of the S_{2n} value at N=77. Such large increase of the S_{2n} values before N=82 was proposed as an alternative to the quenching of the N=82 shell gap to reproduce r-process abundances in the mass region of A=112-124.

Bayesian inference of ion velocity distribution function from laser-induced fluorescence spectra

The velocity distribution function is a statistical description that connects particle kinetics and macroscopic parameters in many-body systems. Laser-induced fluorescence (LIF) spectroscopy is utilized to measure the local velocity distribution function in spatially inhomogeneous plasmas. However, the analytic form of such a function for the system of interest is not always clear under the intricate factors in non-equilibrium states. Here, we propose a novel approach to select the valid form of the velocity distribution function based on Bayesian statistics. We formulate the Bayesian inference of ion velocity distribution function and apply it to LIF spectra locally observed at several positions in a linear magnetized plasma. We demonstrate evaluating the spatial inhomogeneity by verifying each analytic form of the local velocity distribution function. Our approach is widely applicable to experimentally establish the velocity distribution function in plasmas and fluids, including gases and liquids.

Swelling of Doubly Magic ^{48}Ca Core in Ca Isotopes beyond N=28

Interaction cross sections for ^{42-51}Ca on a carbon target at 280  MeV/nucleon have been measured for the first time. The neutron number dependence of derived root-mean-square matter radii shows a significant increase beyond the neutron magic number N=28. Furthermore, this enhancement of matter radii is much larger than that of the previously measured charge radii, indicating a novel growth in neutron skin thickness. A simple examination based on the Fermi-type distribution, and mean field calculations point out that this anomalous enhancement of the nuclear size beyond N=28 results from an enlargement of the core by a sudden increase in the surface diffuseness of the neutron density distribution, which implies the swelling of the bare ^{48}Ca core in Ca isotopes beyond N=28.

Abstract P3-09-04: Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer

[Background] In sporadic breast cancers, the most important gene is p53, given that it is a tumor suppressor gene and mutated in greater than 50% of human cancers. According to previous reports, p53 is also mutated in approximately 20–40% of breast cancers. Recent data from the cancer genome atlas (TCGA) revealed that 37% of breast cancer specimens had alterations in p53-particularly, 72% in (human epidermal growth factor) HER2-rich and 80% of basal-like breast cancer cases—indicating that it is a critical driver of tumor development even in breast cancer. p53 is clinically very important not only because of its high mutation rate but also because mutation is associated with more aggressive disease and worse overall survival. Mitochondria-eating protein (Mieap) is a p53-target gene that plays an important role in mitochondrial quality control. Mieap has been reported to have a critical role in tumorsuppression of colorectal cancer. Here, we investigated the role of Mieap as a tumorsuppressor in breast cancer. [Marerial and methods] We overexpressed Mieap using the constructed adenovirus in breast cancer cell lines such as MCF-7, SK-BR-3, and MDA-MB-231 cells. The percentages of cells in different cell cycle phases (subG1, G1, S, and G2/M) were determined using FACS analysis and also caspase activities (Caspase, 3/7, 9) were measured. Cleaved PARP, which is a marker of cells undergoing apoptosis, was detected by western blot. For in vivo experiments, we examined the expression of Mieap using surgical specimens (invasive ductal carcinomas (IDCs): 75, ductal carcinoma in situ (DCIS): 27, fibroadenomas (FAs): 18) by immunohistochemistry. Next, we performed methylation-specific PCR (MSP) for Mieap, NIX, and BNIP3 promoters and p53-mutation search using 46 samples that were cryopreserved, among 75 IDC cases used for immunohistochemistry. These studies were approved by the central ethics committee of Gifu University.[Results] The enforced-expression of exogenous Mieap in breast cancer cells induced caspase-dependent apoptosis, with activation of both caspase-3/7 and caspase-9. Immunohistochemistry revealed endogenous Mieap in the cytoplasm in 24/75 (32%) invasive ductal carcinomas (IDCs), 15/27 (55.6%) cases of ductal carcinoma in situ (DCIS), and 16/18 (88.9%) fibroadenomas (FAs) (IDC vs DCIS; p = 0.0389, DCIS vs FA; p = 0.0234, IDC vs FA; p < 0.0001). In IDCs, the Mieap promoter was methylated in 6/46 (13%) cases whereas p53 was mutated in 6/46 (13%) cases. Therefore, the p53/Mieap-regulated mitochondrial quality control pathway was inactivated in 12/46 IDCs (26.1%). Interestingly, all of the tumors derived from the 12 patients with the Mieap-promoter methylation or p53 mutation pathologically exhibited more aggressive and malignant phenotype of breast cancers, resulting in significantly shorter disease-free survival (DFS) (p = 0.021). [Conclusion]These results indicate that p53/Mieap-regulated mitochondrial quality control has a critical role in tumor suppression of breast cancer, possibly in part, through mitochondrial apoptotic pathway.

Citation Format: Futamura M, Gaowa S, Arakawa H, Yoshida K. Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P3-09-04.

INVESTIGATION OF A PRACTICAL PATIENT DOSE INDEX FOR ASSESSMENT OF PATIENT ORGAN DOSE FROM CONE-BEAM COMPUTED TOMOGRAPHY IN RADIATION THERAPY USING A MONTE CARLO SIMULATION

The purpose of this study was to investigate a practical patient dose index for assessing the patient organ dose from a cone-beam computed tomography (CBCT) scan by comparing eight dose indices, i.e. CTDI100, CTDIIEC, CTDI∞, midpoint doses f(0)PMMA for a cylindrical polymethyl methacrylate (PMMA) phantom, f(0)Ap for an anthropomorphic phantom and f(0)Pat for a prostate cancer patient, as well as the conventional size specific dose estimations (SSDEconv) and modified SSDE (SSDEmod), with organ dose for the prostate (ODprost) obtained via Monte Carlo (MC) simulation. The ODprost was the reference dose used to find the practical dose index at the center of the pelvic region of a prostate cancer patient. The smallest error rate with respect to the ODprost of 19.3 mGy (reference) among eight dose indices was 5% for f(0)Pat. The practical patient dose index was the f(0)Pat, which showed the smallest error with respect to the reference dose.

Note: Optimization of magnifying a polarization angle with Littrow layout blazed gratings

Magnification of a polarization angle with Littrow layout gratings has been developed. High magnification with a factor of 7.7 using two gratings in Littrow layout was experimentally proved. The magnification range was investigated by calculation at a wavelength of 10.6 μm. The method can be applied for a high magnification factor >30. Larger groove numbers and smaller blaze angles are suitable for the large magnification. Statistical fluctuation of the diffracted polarization angle is compared with that of the incident polarization angle.

A Concept of Cross-Ferroic Plasma Turbulence

The variety of scalar and vector fields in laboratory and nature plasmas is formed by plasma turbulence. Drift-wave fluctuations, driven by density gradients in magnetized plasmas, are known to relax the density gradient while they can generate flows. On the other hand, the sheared flow in the direction of magnetic fields causes Kelvin-Helmholtz type instabilities, which mix particle and momentum. These different types of fluctuations coexist in laboratory and nature, so that the multiple mechanisms for structural formation exist in extremely non-equilibrium plasmas. Here we report the discovery of a new order in plasma turbulence, in which chained structure formation is realized by cross-interaction between inhomogeneities of scalar and vector fields. The concept of cross-ferroic turbulence is developed, and the causal relation in the multiple mechanisms behind structural formation is identified, by measuring the relaxation rate and dissipation power caused by the complex turbulence-driven flux.

Efficient ruthenium sensitizer with an extended π-conjugated terpyridine ligand for dye-sensitized solar cells

A ruthenium sensitizer with an extended π-conjugated terpyridine (TUS-42) has been synthesized for dye-sensitized solar cells (DSCs). Upon extension of the π-conjugated system of the terpyridine ligand, the conversion efficiency of the DSC with TUS-42 improved successfully to 10.7%, which is almost comparable to that of one of the most efficient ruthenium sensitizers (Black dye). Interestingly, an extremely large short-circuit current density (Jsc) value (22.7 mA/cm(2)) was obtained in the DSC with TUS-42 even though the amount of dye adsorption to the TiO2 photoelectrode is relatively small.

Ruthenium sensitizers with a hexylthiophene-modified terpyridine ligand for dye-sensitized solar cells: synthesis, photo- and electrochemical properties, and adsorption behavior to the TiO2 surface

Two novel ruthenium sensitizers with a hexylthiophene-modified terpyridine ligand (TUS-35 and TUS-36) were synthesized to improve the molar absorptivity of the previously reported ruthenium sensitizer (TBA)[Ru{4'-(3,4-dicarboxyphenyl)-4,4″-dicarboxyterpyridine}(NCS)3], TBA = tetrabutylammonium (TUS-21). A relatively strong absorption appeared at ∼380 nm, and the molar absorption coefficient at the metal-to-ligand charge transfer (MLCT) band decreased in TUS-35 by introducing a 2-hexylthiophene unit to the 5-position of the terpyridine-derived ligand. For comparison, a relatively strong absorption was observed at ∼350 nm without decreasing the molar absorption coefficient at the MLCT band in TUS-36 by introducing a 2-hexylthiophene unit to the 4-position of the terpyridine-derived ligand. On the other hand, the energy levels of the highest occupied molecular orbitals and the lowest unoccupied molecular orbitals of these two sensitizers were found to be almost equal to those of TUS-21. The adsorption behavior of TUS-35 and TUS-36 was similar to that of (TBA)[Ru{4'-(3,4-dicarboxyphenyl)terpyridine}(NCS)3] (TUS-20), which binds to the TiO2 surface by using the 3,4-dicarboxyphenly unit, rather than that of TUS-21, which adsorbs to the TiO2 photoelectrode using one of the carboxyl groups at the terminal pyridines of the terpyridine-derived ligand. Therefore, TUS-35 and TUS-36 are considered to bind to the TiO2 surface by using the 3,4-dicarboxyphenly unit just like TUS-20. The dye-sensitized solar cells (DSCs) with TUS-35 and TUS-36 showed a relatively lower conversion efficiency (6.4% and 5.7%, respectively) compared to the DSC with TUS-21 (10.2%). Open-circuit photovoltage decay and electrochemical impedance spectroscopy measurements revealed that the promoted charge recombination and/or charge transfer of the injected electrons in the TiO2 photoelectrode is a main reason for the inferior performances of TUS-35 and TUS-36.

Novel near-infrared carboxylated 1,3-indandione sensitizers for highly efficient flexible dye-sensitized solar cells

The novel near-infrared organic dyes were designed for use in plastic-substrate dye sensitized solar cells. As a result, η of 5.76% was achieved.

Note: Magnification of a polarization angle with a Littrow layout brazed grating

A new method to magnify a small polarization angle with brazed gratings has been developed. In the method, difference in diffraction efficiency for S and P polarization components is used. The magnification dependence on the incident angle can be small by arranging the grating in Littrow layout. A magnification with a factor ~2.7 has been demonstrated for a 10.6 μm CO2 laser beam as expected from a calculation. The method is applicable in many polarimetry fields.

Novel ruthenium sensitizers with a dianionic tridentate ligand for dye-sensitized solar cells: the relationship between the solar cell performances and the electron-withdrawing ability of substituents on the ligand

Five novel ruthenium sensitizers (TUS sensitizers) with a dianionic tridentate ligand (pyridine-2,6-dicarboxyamidato and its derivatives) have been synthesized for application to dye-sensitized solar cells (DSCs). These TUS sensitizers have much larger molar absorption coefficients in the wavelength range below 600 nm compared with those of Black dye which is a structural analog and a highly efficient ruthenium sensitizer. The energy levels of HOMOs and LUMOs of TUS sensitizers shifted to the positive direction with increasing the electron-withdrawing ability of the substituents on the dianionic tridentate ligand. The energy levels of HOMO and LUMO showed linear correlation with respect to the Hammett constant of the substituents. The DSCs with TUS sensitizers showed much lower performances than that of Black dye. Both inferior adsorptivity on the TiO2 surface and unfavorable energy levels of HOMOs and LUMOs for the effective electron transfer reactions in the DSCs are considered to be the main reasons for the much lower performances of TUS sensitizers. The conversion efficiency of the DSC with a TUS sensitizer increased with increasing the electron-withdrawing ability of the substituents on the dianionic tridentate ligand. The observed linear relationship between the conversion efficiency and the driving force of the reduction process of the oxidized form of dyes by I(-) suggests that the dye regeneration process is a rate-determining step in the DSCs with TUS sensitizers.

Natural course of dissecting vertebrobasilar artery aneurysms without stroke

BACKGROUND AND PURPOSE

The natural history and therapeutic management of dissecting vertebrobasilar aneurysms without ischemic or hemorrhagic stroke (nonstroke dissecting vertebrobasilar aneurysms) are not well-established. We conservatively followed patients with nonstroke dissecting vertebrobasilar aneurysms and evaluated the factors related to clinical and morphologic deterioration.

MATERIALS AND METHODS

One hundred thirteen patients were enrolled and divided by clinical presentation at diagnosis: asymptomatic (group 1, n = 52), pain only (group 2, n = 56), and mass effect (group 3, n = 5). Patients were conservatively managed without intervention and antithrombotic therapy. Clinical outcomes and morphologic changes were analyzed.

RESULTS

A total of 113 patients who were diagnosed with nonstroke dissecting vertebrobasilar aneurysm had a mean follow-up of 2.9 years (range, 27 days to 8 years). Throughout that period, 1 patient in group 1 (1.9%) and 1 patient in group 2 (1.8%) showed clinical deterioration due to mass effect, and 1 patient in group 3 (20%) developed ischemic stroke followed by subarachnoid hemorrhage. Most patients (97.3%) were clinically unchanged. Three patients who had clinical deterioration showed aneurysm enlargement (P < .001). Aneurysms remained morphologically unchanged in 91 patients (80.5%). Aneurysm enlargement was seen in 5 patients (4.4%); risk of enlargement was significantly associated with either maximum diameter (hazard ratio = 1.30; 95% CI, 1.11-11.52; P = .001) or aneurysm ≥10 mm (hazard ratio = 18.0; 95% CI, 1.95-167; P = .011).

CONCLUSIONS

The natural course of these lesions suggests that acute intervention is not always required and close follow-up without antithrombotic therapy is reasonable. Patients with symptoms due to mass effect or aneurysms of >10 mm may require treatment.

A new cosensitization method using the Lewis acid sites of a TiO2 photoelectrode for dye-sensitized solar cells

Dye-sensitized solar cells co-sensitized with black dye and a pyridine-anchor dye showing site-selective adsorption behaviour at the TiO₂ surface have been prepared for the first time to reduce competitive adsorption.

Ruthenium sensitizers having an ortho-dicarboxyl group as an anchoring unit for dye-sensitized solar cells: synthesis, photo- and electrochemical properties, and adsorption behavior to the TiO2 surface

A novel ruthenium sensitizer with a 3′,4′-dicarboxyterpyridine (TUS-28) has been synthesized as an improved model sensitizer of the dye-sensitized solar cells.

Validation and initial application of a semiautomatic aneurysm measurement software: a tool for assessing volumetric packing attenuation

BACKGROUND AND PURPOSE

Precise aneurysm measurements and volume embolization ratios are essential for long-term durability of endovascular coil embolization. We evaluated the accuracy of newly developed semiautomatic cerebral aneurysm measurement software, NeuroVision, and explored the value of volume embolization ratio in the prediction of re-treatment.

MATERIALS AND METHODS

We compared software-derived volume measurements of 4 silicone aneurysm models with those calculated with an approximation formula and ground truth values (validation study). We used NeuroVision to retrospectively evaluate outcomes of 100 unruptured aneurysms (97 patients) treated with embolization (clinical study). Aneurysm size (height, width, and neck), volume, and volume embolization ratios were calculated for 3 groups (stable, recanalization, and re-treatment) and were compared.

RESULTS

This validation study illustrated higher accuracy of NeuroVision in computing aneurysm volume compared with an approximation formula: percentage absolute errors were 4.50% ± 3.18% and 23.07% ± 17.60%, with maximal percentage absolute errors of 8.99% and 45.63%, respectively. Of 100 unruptured aneurysms, 20 recanalized and 12 were re-treated. Average volume embolization ratios of stable and re-treated aneurysms were 24.88% ± 5.91% and 20.50% ± 4.06%, respectively (P ≤ .01). The optimal volume embolization ratio cutoff point for re-treatment was < 19.15%, at which the Youden index was 0.50 (sensitivity, 58.33%; specificity, 87.50%; area under the receiver operating characteristic curve, 0.74).

CONCLUSIONS

The NeuroVision software provided accurate aneurysm volume measurements and may be a useful standardized tool to measure aneurysm size and volume, especially for multicenter clinical studies. Volume embolization ratio may be a valuable predictor of aneurysm occlusion changes.

'I-shaped' sign in the upper mediastinum: a novel potential marker for antenatal diagnosis of d-transposition of the great arteries

OBJECTIVES

To investigate the 'I-shaped' sign as a novel echocardiographic marker for antenatal diagnosis of d-transposition of the great arteries (dTGA) in routine cardiac examination, and to compare its prevalence in fetuses with dTGA, those with other congenital heart diseases (CHDs) and those with normal structural hearts.

METHODS

This retrospective evaluation involved 1134 fetuses undergoing echocardiography to screen for CHD over a 4-year period. I-shaped sign was defined as the characteristic appearance of the aortic arch, resembling the letter 'I', from the most anterior to the most posterior point of the descending aorta visible in the three vessels and trachea view. The frequency of this sign was evaluated in cases with dTGA, those with other cardiac defects and those with normal cardiac structures.

RESULTS

CHD was diagnosed in 671 (59.1%) cases, of which 31 (4.6%) had dTGA. I-shaped sign was observed in 30/31 (96.8%) cases of dTGA, compared with 31/640 (4.8%) cases with other cardiac anomalies, which included single ventricle with pulmonary atresia or severe pulmonary stenosis, hypoplastic left heart syndrome with aortic atresia, corrected transposition of the great arteries, and double outlet right ventricle with malposition of the great arteries. I-shaped sign was detected significantly more frequently in the dTGA group compared with the normal group and with the other CHDs group (both P < 0.001) and had 96.8% sensitivity and 97.1% specificity for diagnosis of dTGA. Importantly, I-shaped sign was never observed in fetuses with structurally normal hearts.

CONCLUSIONS

Detection on echocardiography of an extremely long vessel with a marked I-shape should raise suspicion of cardiac anomaly, especially dTGA. This marker may therefore aid in the prenatal diagnosis of dTGA during routine ultrasound examination.

Justification of unruptured intracranial aneurysm repair: a single-center experience

BACKGROUND AND PURPOSE

Whether to treat UIAs is controversial. The aim of the study was to compare the clinical outcome of patients with UIAs who were either treated conservatively or preventively.

MATERIALS AND METHODS

Patients with UIAs referred to our institution were prospectively enrolled in the study. Data collected included baseline characteristics, aneurysmal features, and procedural and follow-up information. Preventive treatment was recommended if the aneurysm was larger than 5 mm and was considered safely treatable. Endovascular surgery was the first-line therapy if the aneurysmal shape was appropriate for coiling.

RESULTS

From January 2003 through April 2008, a total of 879 patients with 1110 UIAs were enrolled; 325 patients with 369 UIAs (mean size, 7.8 mm) were treated (treatment group), and 603 patients with 741 UIAs (mean size, 4.4 mm) were managed conservatively (observation group). Mean follow-up was 692.5 days (1405.5 person-years). In the observation group, 26 aneurysms (3.5%) had ruptured (1.8% per year; 1405.5 person-years), 10 patients died, and 7 were disabled (mRS, 3-6: 2.8%). Aneurysmal size was a significant risk factor for rupture (P = .001). The treatment group included aneurysms treated either with coiling (n=315), clipping (n=32), or a combined approach (n=9); 1 patient died, and 3 were disabled (mRS, 3-6: 1.2%). Therapeutic intervention was equal (UIAs of all sizes) or superior (UIAs > 5 mm; P = .025) to conservative management.

CONCLUSIONS

Treatment of UIAs was justified in aneurysms larger than 5 mm, and EVS can be safely applied to nearly 90% of UIAs.

Development of a novel telomerase assay using the PPDK-luciferin-luciferase detection system

Telomerase participates in malignant transformation or immortalization of cells, and has attracted attention as an anticancer drug screening and diagnostic tumor marker. We developed a novel telomerase assay called the PPDK-luciferin-luciferase system bioluminescence assay (PLLBA) using pyruvate phosphate dikinase (PPDK). In this assay, pyrophosphate produced by the telomerase reaction and polymerase chain reaction (PCR) is converted to ATP by PPDK, and ATP is detected by the firefly luciferin-luciferase reaction. In this work, telomerase substrate was obtained in accordance with the telomeric repeat amplification protocol (TRAP). Telomerase-positive (500 cells/assay), -inactive (heated for 10 min at 85 °C) and -negative (only Chaps lysis buffer) samples were used. As a result, the findings clearly showed that the signal-to-noise (S/N) ratio of the positive cells was 39.5. After the telomerase reaction and PCR, PLLBA was completed ~ 120 s later. A high level of reproducibility was obtained with - coefficient of variation (CV) of 4.1% (positive cells). The detection limit for cells using telomerase was one cell per assay. This assay for telomerase activity was also shown to be adaptable to human cancer-derived cell lines.

Identification of errors in the electron density measurements of a tangential interferometer∕polarimeter system during a tokamak discharge

A new method for the comparative verification of electron density measurements obtained with a tangential interferometer and a polarimeter during a discharge is proposed. The possible errors associated with the interferometer and polarimeter are classified by the time required for their identification. Based on the characteristics of the errors, the fringe shift error of the interferometer and the low-frequency noise of the polarimeter were identified and corrected for the JT-60U tangential interferometer∕polarimeter system.

International consensus on (ICON) pediatric asthma

Asthma is the most common chronic lower respiratory disease in childhood throughout the world. Several guidelines and/or consensus documents are available to support medical decisions on pediatric asthma. Although there is no doubt that the use of common systematic approaches for management can considerably improve outcomes, dissemination and implementation of these are still major challenges. Consequently, the International Collaboration in Asthma, Allergy and Immunology (iCAALL), recently formed by the EAACI, AAAAI, ACAAI, and WAO, has decided to propose an International Consensus on (ICON) Pediatric Asthma. The purpose of this document is to highlight the key messages that are common to many of the existing guidelines, while critically reviewing and commenting on any differences, thus providing a concise reference. The principles of pediatric asthma management are generally accepted. Overall, the treatment goal is disease control. To achieve this, patients and their parents should be educated to optimally manage the disease, in collaboration with healthcare professionals. Identification and avoidance of triggers is also of significant importance. Assessment and monitoring should be performed regularly to re-evaluate and fine-tune treatment. Pharmacotherapy is the cornerstone of treatment. The optimal use of medication can, in most cases, help patients control symptoms and reduce the risk for future morbidity. The management of exacerbations is a major consideration, independent of chronic treatment. There is a trend toward considering phenotype-specific treatment choices; however, this goal has not yet been achieved.

Characterization of photovoltaic performance of the dye-sensitized solar cell with a novel ruthenium complex having a bisdemethoxycurcumin as a ligand

The first example of a ruthenium sensitizer (TUS-22) having a natural dye, bisdemethoxycurcumin, as a ligand has been synthesized. The dye-sensitized solar cell based on this novel dye showed 5.8% conversion efficiency under AM 1.5 (100 mW/cm(2)) irradiation.

Observation of long-distance radial correlation in toroidal plasma turbulence

This Letter presents the discovery of macroscale electron temperature fluctuations with a long radial correlation length comparable to the plasma minor radius in a toroidal plasma. Their spatiotemporal structure is characterized by a low frequency of ∼1-3  kHz, ballistic radial propagation, a poloidal or toroidal mode number of m/n=1/1 (or 2/1), and an amplitude of ∼2% at maximum. Nonlinear coupling between the long-range fluctuations and the microscopic fluctuations is identified. A change of the amplitude of the long-range fluctuation is transmitted across the plasma radius at the velocity which is of the order of the drift velocity.

Observation of quasi-two-dimensional nonlinear interactions in a drift-wave streamer

A streamer, which is a bunching of drift-wave fluctuations, and its mediator, which generates the streamer by coupling with other fluctuations, have been observed in a cylindrical magnetized plasma. Their radial structures were investigated in detail by using the biphase analysis. Their quasi-two-dimensional structures were revealed to be equivalent with a pair of fast and slow modes predicted by a nonlinear Schrödinger equation based on the Hasegawa-Mima model.

A novel nonsecosteroidal VDR agonist (CH5036249) exhibits efficacy in a spontaneous benign prostatic hyperplasia beagle model

To date, there have been no reports showing the efficacy of nonsecosteroidal vitamin D receptor (VDR) agonists in a benign prostatic hyperplasia (BPH) animal model. To examine the efficacy of CH5036249, a novel nonsecosteroidal VDR agonist, we orally administered the compound at 0.03 microg/kg to a beagle model with spontaneous BPH. Prostate volume was checked by rectal ultrasonic probe periodically during 11 months of administration and the prostate tissues histologically examined. CH5036249 inhibited prostate growth in two out of three dogs compared with vehicle-treated dogs. In the prostate specimens, substantial atrophy of the epithelium was observed in all dogs administered CH5036249. At the dose given, serum calcium levels slightly increased in the CH5036249-treated dogs but stayed within a normal range. We next examined the cell growth inhibition of CH5036249 using human prostate stromal cells and found the cell growth inhibitory activity of CH5036249 to be comparable to that of 1alpha,25(OH)2D3. The bioavailability from oral administration in rats was 95.1% with a t1/2 of 17.6 h. Both micro-AMES and micronucleus tests were negative. Although the results are still preliminary, we consider the novel nonsecosteroidal VDR agonist CH5036249 to be a possible new drug candidate for the treatment of BPH in humans.